The effect of tiotropium bromide on exhaled breath temperature in patients with stable chronic obstructive pulmonary disease

Trial Profile

The effect of tiotropium bromide on exhaled breath temperature in patients with stable chronic obstructive pulmonary disease

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Nov 2013

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Nov 2013 New trial record
    • 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top